Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients.

Papautsky, Elizabeth Lerner; Carlson, Martha; Johnson, Sheila M; Montague, Hannah; Attai, Deanna J; Lustberg, Maryam B

Papautsky, Elizabeth Lerner; Carlson, Martha; Johnson, Sheila M; Montague, Hannah; Attai, Deanna J; Lustberg, Maryam B.

Afiliação

Papautsky EL; Department of Biomedical & Health Information Sciences, University of Illinois at Chicago, 1919 W. Taylor St., Chicago, IL, 60612, USA. elp@uic.edu.
Carlson M; , Chicago, IL, USA.
Johnson SM; , Swansea, IL, USA.
Montague H; Department of Biomedical & Health Information Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Attai DJ; Department of Surgery, University of California Los Angeles, Los Angeles, CA, USA.
Lustberg MB; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA.

Breast Cancer Res Treat ; 194(1): 25-33, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35568748

Assuntos

Medicamentos Biossimilares; Neoplasias da Mama; Oncologistas; Medicamentos Biossimilares/uso terapêutico; Neoplasias da Mama/tratamento farmacológico; Feminino; Humanos; Internet; Trastuzumab/uso terapêutico

Palavras-chave

Biosimilars; Breast cancer; Communication; Patient-centered care; Patient-provider communication; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Medicamentos Biossimilares / Oncologistas Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google